AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India · Delayed Price · Currency is INR 9,010.00
-61.50 (-0.68%)
Sep 12, 2025, 3:30 PM IST
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 225.11 billion as of September 12, 2025. Its market cap has increased by 33.50% in one year.
Market Cap
225.11B
Enterprise Value
220.10B
Revenue
18.55B
Ranking
n/a
PE Ratio
122.77
Stock Price
9,010.00
Market Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 225.11B, an increase of 15,424.48%. That is a compound annual growth rate of 23.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 225.11B | 23.18% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | 115.54B | 76.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,862.21B |
| Divi's Laboratories | 1,596.93B |
| Cipla | 1,260.74B |
| Apollo Hospitals Enterprise | 1,132.95B |
| Mankind Pharma | 1,072.76B |
| Zydus Lifesciences | 1,050.11B |
| Fortis Healthcare | 729.25B |
| Alkem Laboratories | 644.87B |